What Is an Ejection Fraction and What Does Your Number Actually Mean?

Ejection fraction (EF) is the percentage of blood the left ventricle pumps out with each heartbeat. A normal EF is 55% to 70%, meaning the heart ejects more than half its volume with every beat. It's the single most important measure of how well the heart's main pumping chamber is functioning, and it's calculated during an echocardiogram using real-time ultrasound. When patients get their echo report back and see a number they don't recognize, this is typically the one they're trying to understand.

What the Ejection Fraction Ranges Actually Mean

The American Heart Association defines four clinical categories based on EF, each carrying different implications for management and monitoring. (American Heart Association, 2023). Understanding which category your number falls into is the starting point for every conversation about cardiac function.

Keep in mind that a single number never tells the whole story. An EF of 52% in someone whose baseline was always 65% means something different from an EF of 52% in someone who has always measured there. That's why a baseline study, before any suspected problem develops, is genuinely useful.

How Is Ejection Fraction Measured?

Ejection fraction is most reliably measured by echocardiogram using the Simpson's biplane method, which is the standard recommended by the American Society of Echocardiography. (Lang et al., Journal of the American Society of Echocardiography, 2015). This method traces the outline of the left ventricular cavity in two imaging planes at two points in the cardiac cycle.

The two measurements are end-diastolic volume (EDV) - the cavity at full filling - and end-systolic volume (ESV) - the cavity after full contraction. The formula is straightforward: EF = (EDV minus ESV) divided by EDV, expressed as a percentage. If the heart fills to 120 mL and contracts down to 50 mL, the EF is about 58%.

Older methods include M-mode and 2D linear measurements, which estimate EF from a single diameter rather than a full volume. These are faster but less accurate, particularly when wall motion is not uniform throughout the ventricle. For any patient with known or suspected cardiac disease, Simpson's biplane is the method we use.

What Is the Difference Between HFrEF and HFpEF?

Heart failure is not a single disease. It comes in two fundamentally different forms, and ejection fraction is what separates them. Heart failure with reduced ejection fraction (HFrEF) occurs when the EF falls below 40% - the heart is weak and cannot pump a sufficient volume of blood forward. Heart failure with preserved ejection fraction (HFpEF) occurs when the EF is 50% or above, but the muscle is stiff and does not relax normally during filling.

HFpEF accounts for roughly 50% of all heart failure cases and is especially common in older adults, women, and patients with hypertension or obesity, according to the Cleveland Clinic. (Cleveland Clinic, 2024). Both forms cause the same symptoms - shortness of breath, fatigue, and fluid retention - but require different treatment strategies.

The distinction matters clinically because a normal EF does not mean a normal heart. Patients with HFpEF often receive reassurance based on a preserved ejection fraction while their diastolic dysfunction, elevated filling pressures, and elevated pulmonary artery pressures go unaddressed. An echocardiogram evaluates all of these parameters, not just the ejection fraction in isolation. For a full explanation of what your echo report contains, see our guide to reading your echocardiogram report.

What Causes a Low Ejection Fraction?

Coronary artery disease is the leading cause of reduced EF, responsible for approximately 60-70% of cases of dilated cardiomyopathy with systolic dysfunction. When coronary disease causes a heart attack, the affected region of the ventricular wall loses its ability to contract normally. The extent of the damage, and how much viable but stunned muscle remains, determines how much function can be recovered.

Other common causes include dilated cardiomyopathy (where the heart muscle weakens and the ventricle enlarges without a clear blockage), long-standing uncontrolled hypertension, significant valve disease that chronically volume- or pressure-overloads the ventricle, and viral myocarditis. Certain chemotherapy agents - particularly anthracyclines like doxorubicin - are well-established causes of cardiotoxicity and reduced EF, which is why cardiac monitoring is standard during and after cancer treatment.

What's worth understanding is the concept of reversibility. An EF reduced by active ischemia, viral myocarditis, or medication toxicity may recover substantially once the cause is treated. An EF reduced by extensive scar tissue from prior infarction generally will not recover to the same degree. The imaging findings that distinguish viable from scarred myocardium - wall thinning, bright echo texture, lack of systolic thickening - are visible on a standard echocardiogram and are part of what we report.

Can Ejection Fraction Improve with Treatment?

Yes, significantly. This is one of the most important points in heart failure management, and one that many patients aren't told clearly enough. Guideline-directed medical therapy (GDMT) for HFrEF - which includes ACE inhibitors or ARNIs, beta-blockers, mineralocorticoid receptor antagonists, and SGLT2 inhibitors - has been shown in randomized trials to improve EF by a mean of 8 to 20 percentage points in responsive patients. Some patients see their EF normalize entirely.

A category of patients called "HFrecEF" - heart failure with recovered ejection fraction - describes those whose EF improves to 50% or above with treatment. Studies published in the Journal of the American College of Cardiology show that even patients with fully recovered EF benefit from continuing their medications long-term. Stopping treatment commonly leads to relapse, even when the EF looks entirely normal on repeat imaging.

Lifestyle changes also matter. Blood pressure control, weight reduction, sodium restriction, aerobic exercise training, and alcohol cessation have all been associated with measurable improvements in cardiac function. The heart is not a static organ - it responds to the demands and conditions placed on it, and that response is measurable by serial echocardiography.

What Should You Do If Your Ejection Fraction Is Low?

First, understand that a single echo report is a data point, not a verdict. What it tells you is where the heart's function stands right now - not what caused it to get there, not what the trajectory has been, and not what it will look like after treatment. That context requires a cardiologist to interpret the findings alongside your symptoms, your history, and often additional testing.

From an imaging standpoint, a reduced EF warrants investigation of the underlying cause, assessment of the severity of any wall motion abnormalities, quantification of any valve dysfunction that may be contributing, and evaluation of right heart function and pulmonary pressures. These are all components of a standard echocardiogram report. None of them require additional testing to obtain.

If the EF is unexpectedly low on a study you ordered yourself - as a baseline or due to symptoms - bring the report to your physician. A cardiologist referral is appropriate. If you're already under cardiology care, serial imaging typically continues every 3 to 12 months depending on severity, treatment response, and whether intervention is being considered.

Why Does Getting a Baseline Ejection Fraction Matter?

An EF of 50% means one thing if your previous study showed 65% and another thing entirely if every study has always shown 50%. Without a baseline, there's no way to know which situation you're in. This is the clinical argument for getting an echocardiogram before symptoms develop - not because a single abnormal finding will change your life, but because a normal baseline dramatically increases the interpretability of any future study.

In my work performing mobile echocardiograms, I see this scenario regularly: a patient in their 50s or 60s has a study ordered after a new finding, and there's no prior imaging to compare against. The report shows an EF of 52%. Is that a decline from a previously normal heart? Or has it always been at the lower end of normal? We don't know. The clinical team doesn't know. And the management decision - whether to investigate further, start therapy, or simply monitor - becomes harder to make confidently.

Baseline echocardiography is particularly relevant for patients with hypertension, a family history of cardiomyopathy, or those starting cardiotoxic chemotherapy agents. In those populations, knowing where the EF starts allows treatment and monitoring decisions to be made with actual data rather than estimates.

No referral required  ·  Mobile service throughout Southern Maine  ·  Results in 24-48 hours

Frequently Asked Questions

What is a normal ejection fraction?

A normal left ventricular ejection fraction is 55% to 70%, according to the American Heart Association. Values between 41% and 54% are considered mildly reduced. Values between 35% and 40% are moderately reduced. Below 35% is severely reduced and meets criteria for advanced heart failure evaluation. A preserved EF (50% or above) does not rule out heart failure if diastolic function is abnormal.

What does a low ejection fraction mean?

A low ejection fraction - below 40% - means the left ventricle is not contracting with enough force to eject an adequate volume of blood per beat. This is the defining criterion for heart failure with reduced ejection fraction (HFrEF). It doesn't always cause immediate symptoms, which is why it's sometimes found incidentally. The underlying cause needs to be identified because it determines what treatment is appropriate.

How is ejection fraction measured?

The standard method is Simpson's biplane, performed during a transthoracic echocardiogram. The sonographer traces the left ventricular cavity in two views at end-diastole (full) and end-systole (contracted). The software calculates the volumes and derives the ejection fraction. The test takes 30 to 60 minutes, uses no radiation, and requires no preparation or recovery time.

Can ejection fraction improve?

Yes. With appropriate guideline-directed medical therapy, many patients with reduced EF see improvements of 8 to 20 percentage points. Some recover to a normal EF entirely - a condition now called HFrecEF. The degree of recovery depends on the cause: ischemic disease with extensive scar tends to recover less than non-ischemic cardiomyopathy or myocarditis. Serial echocardiograms track this response over time.

What is HFpEF and how is it different from a low ejection fraction?

HFpEF is heart failure with preserved ejection fraction - the EF is 50% or above, but the heart muscle is stiff and doesn't relax normally during filling. Patients still experience fluid retention, shortness of breath, and exercise intolerance despite a normal pumping percentage. It accounts for roughly half of all heart failure cases. Diagnosis requires echocardiographic assessment of diastolic function, not just the EF alone.

What causes a low ejection fraction?

Coronary artery disease is the most common cause, accounting for 60-70% of systolic heart failure. Other causes include dilated cardiomyopathy, long-standing hypertension, significant valve disease (particularly aortic stenosis and mitral regurgitation), viral myocarditis, and cardiotoxic chemotherapy. In some cases no clear cause is found, which is termed idiopathic cardiomyopathy. An echocardiogram identifies the EF and may reveal the structural cause, but additional testing is often needed.